Idorsia’s Quviviq Needs To Rise And Shine After Slow Launch
US Coverage Negotiations And Celebrity DTC Will Be Significant
The company’s Quviviq launch has fallen short of early expectations, but Idorsia believes a patient approach will pay off for the blockbuster-tipped insomnia treatment.
